AI drug discovery firm Insilico Medicine signs deal with Korea’s SK Biopharmaceuticals worth $2.5B
Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK Biopharmaceuticals to help develop ...
Insilico Medicine, the Hong Kong-listed AI drug discovery company, has signed a partnership with Korea’s SK Biopharmaceuticals to help develop ...
Part the First: Predatory or Not? Over the past six years the biomedical literature has accumulated 494,547 scientific “publications” with ...
The chief legal officer of Disc Medicine sold 6,500 shares of the company for $511,472 on Jan. 2. The sale ...
This week, Kenvue, the consumer health spin-off from Johnson & Johnson, found itself at the epicenter of a market tempest ...
President Donald Trump has picked Jim O’Neill, a former investor and critic of health regulations serving under Health Secretary Robert ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.